Head-to-head · Cost-Efficiency Index
Jently vs StackMD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Jently
Shoppers who specifically want a named, checkable compounding pharmacy partner.
Visit JentlyStackMD
Shoppers price-scanning for the lowest advertised entry point, who should confirm true dose-adjusted cost before signing up.
Visit StackMDThe verdict
Jently and StackMD tie on the Cost-Efficiency Index at 60/100, so neither wins outright on the numbers. For most shoppers we'd start with Jently (ranked #250, a hair above #257) — Shoppers who specifically want a named, checkable compounding pharmacy partner. But StackMD is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Jently.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Jently | StackMD |
|---|---|---|
| Cost-Efficiency Index | 60/100 | 60/100 |
| Semaglutide / mo | $124/mo (plus a separate fee, compounded) | Not disclosed |
| Tirzepatide / mo | $174/mo (compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $1,488 | — |
| Tirzepatide / yr (modeled) | $2,088 | — |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #250 | #257 |
Jently
60/100Where the value is
- Names an actual compounding pharmacy (Precision Compounding Pharmacy, Bellmore NY) with a real address
- LegitScript badge present with verification link
- Low advertised entry price for semaglutide ($124/mo 'as low as')
The tradeoffs
- Pricing is inconsistent between the site's own pages ($124-199 range with no clear reconciliation)
- 'Founding Member Price-Lock' framing implies a future price increase for non-founding members
StackMD
60/100Where the value is
- Low advertised entry price ($99/mo) for both semaglutide and tirzepatide
- Clear FDA-compounding disclaimer shown up front
- Distinct national telehealth brand (separate from the similarly-named Long Island clinic)
The tradeoffs
- Identical $99 headline for both drugs strongly suggests a lowest-dose teaser, not full treatment pricing
- No dose tiers, medical director, pharmacy name, states list, or LegitScript status could be confirmed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.